アラマー・バイオサイエンシズ
Alamar Biosciences, Inc.
Alamar Biosciences is a commercial-stage proteomics company focused on ultra-sensitive, multiplexed protein detection for research and future clinical applications. Its platform combines proprietary instruments, consumables, and software to provide an end-to-end system for measuring multiple low-abundance proteins across research and potential clinical applications.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.31 | $26M | -$21M |